Injections in the Diagnosis and Treatment of Lumbar Facet Syndrome
Launched by COMPLEJO HOSPITALARIO UNIVERSITARIO DE GRANADA · Mar 10, 2019
Trial Information
Current as of May 20, 2025
Unknown status
Keywords
ClinConnect Summary
Facet joint pain is considered as a nonspecific cause of spinal pain with an estimated prevalence of 12-61% of the population. At present, there are no unanimous clinical criteria to achieve and accurate diagnosis and the imaging findings do not show a direct correlation with the clinical symptoms.
Facet syndrome treatment is also controversial and, although most clinical guidelines recommend nerve block as a diagnostic test, followed by neurolysis as therapeutic technique, there are many detractors of this therapeutic sequence.
The confusion is even greater when considering the variabili...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1- Lumbar facet syndrome diagnosed by the referring specialist: Rehabilitation, Traumatology or Neurosurgery 2 -Mechanical low back pain that increases with rotation and flexion-extension, without radicular irradiation.
- • 3- failure of conservative treatment (pharmacological and physical therapy). 4-Symptoms present more than 3 months
- Exclusion Criteria:
- • 1. Previous back surgery and other ablative treatments.
- • 2. Contraindication for the use of corticosteroid or local anesthetic.
- • 3. Uncontrolled acute or chronic medical illness.
- • 4. Pregnancy or lactation.
- • 5. Presence of inflammatory arthropathy or neuropathy.
- • 6. Wounds or skin lesions in the area.
- • 7. Diabetes mellitus.
- • 8. Psychiatric disorders
- • 9. Refusal to participate in the study.
- • 10. Demonstration by imaging techniques of other causes that could justify the symptomatology.
About Complejo Hospitalario Universitario De Granada
The Complejo Hospitalario Universitario de Granada is a distinguished healthcare institution dedicated to providing high-quality medical care, education, and research. As a leading academic hospital in Spain, it integrates advanced clinical services with a robust training environment for healthcare professionals. The hospital is actively involved in clinical trials, focusing on innovative therapies and treatment protocols to enhance patient outcomes. By fostering collaboration among multidisciplinary teams, the Complejo Hospitalario Universitario de Granada contributes significantly to the advancement of medical knowledge and the development of evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Granada, Spa, Spain
Granada, , Spain
Patients applied
Trial Officials
FERNANDO RUIZSANTIAGO, PhD
Principal Investigator
HOSPITAL DE NEURO-TRAUMATOLOGIA GRANADA (VIRGEN DE LAS NIEVES)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials